Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VENTAVIS Cause General physical health deterioration? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of General physical health deterioration have been filed in association with VENTAVIS. This represents 4.6% of all adverse event reports for VENTAVIS.

17
Reports of General physical health deterioration with VENTAVIS
4.6%
of all VENTAVIS reports
12
Deaths
11
Hospitalizations

How Dangerous Is General physical health deterioration From VENTAVIS?

Of the 17 reports, 12 (70.6%) resulted in death, 11 (64.7%) required hospitalization, and 1 (5.9%) were considered life-threatening.

Is General physical health deterioration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VENTAVIS. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does VENTAVIS Cause?

Dyspnoea (63) Death (62) Pulmonary arterial hypertension (40) Fatigue (26) Malaise (26) Pneumonia (26) Drug dose omission (21) Headache (21) Fluid retention (19) Pulmonary hypertension (18)

What Other Drugs Cause General physical health deterioration?

METHOTREXATE (5,767) ADALIMUMAB (5,718) INFLIXIMAB (5,403) RITUXIMAB (5,178) ABATACEPT (4,832) LEFLUNOMIDE (4,420) PREDNISONE (4,402) LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (4,332) TOCILIZUMAB (4,254) ETANERCEPT (3,898)

Which VENTAVIS Alternatives Have Lower General physical health deterioration Risk?

VENTAVIS vs VENTOLIN VENTAVIS vs VENTOLIN HFA VENTAVIS vs VERAPAMIL VENTAVIS vs VERICIGUAT VENTAVIS vs VERTEPORFIN

Related Pages

VENTAVIS Full Profile All General physical health deterioration Reports All Drugs Causing General physical health deterioration VENTAVIS Demographics